tirzepatide compound with glycine Dr. Friedman's Weight Loss Guide Compounded Semaglutide/Tirzepatide: Personalized, Affordable Medical

Risk factors include renal impairment, concomitant use of certain drugs, age 65 years old, radiological studies with contrast, surgery and other procedures, hypoxic states, excessive alcohol intake, and hepatic impairment

Red flags that require immediate provider consultation: severe GI symptoms, chest pain or heart palpitations, significant mood changes, severe fatigue despite adequate sleep, any neurological symptoms, or persistent symptoms despite supplementation

They are reasonable assumptions based on pharmacological principles

A clinician can help assess your symptoms and recommend appropriate support or treatment

Trace Curry is the Medical Director of JourneyLite Surgery Center and JourneyLite Physicians

Oral tirzepatide drops have zero published clinical trial data